PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Biotechnology and Genetic Engineering, Faculty of Life Science, Mawlana Bhashani Science and Technology University, Tangail-1902, Bangladesh; Aristopharma Limited, Bangladesh. Electronic address: arafatr@outlook.com.\', \'Department of Biotechnology and Genetic Engineering, Faculty of Life Science, Mawlana Bhashani Science and Technology University, Tangail-1902, Bangladesh; Department of Medical Biotechnology, Bangladesh University of Health Sciences, Dhaka, Bangladesh.\', \'Biotechnology and Genetic Engineering Discipline, Life Science School, Khulna University, Khulna, Bangladesh.\', \'Molecular Modeling Drug-design and Discovery Laboratory, Pharmacology Research Division, BCSIR Laboratories Chattogram, Bangladesh Council of Scientific and Industrial Research, Chattogram, Bangladesh.\', \'Molecular Modeling Drug-design and Discovery Laboratory, Pharmacology Research Division, BCSIR Laboratories Chattogram, Bangladesh Council of Scientific and Industrial Research, Chattogram, Bangladesh; Pancreatic Research Group, South Western Sydney Clinical School, and Ingham Institute for Applied Medical Research, Faculty of Medicine, University of New South Wales, Sydney, Australia.\', \'WHO Collaborating Centre on eHealth, UNSW Digital Health, School of Public Health and Community Medicine, Faculty of Medicine, UNSW Sydney, Australia. Electronic address: m.moni@unsw.edu.au.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0924-8579(20)30383-610.1016/j.ijantimicag.2020.106177
?:doi
?:hasPublicationType
?:journal
  • International journal of antimicrobial agents
is ?:pmid of
?:pmid
?:pmid
  • 32987103
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.699
?:rankingScore_hIndex
  • 107
?:title
  • Design of novel viral attachment inhibitors of the spike glycoprotein (S) of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) through virtual screening and dynamics.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all